Exchange Announcement • 20 Mar 2023 21:58
Exchange Announcement • 10 Mar 2023 21:11
Exchange Announcement • 10 Mar 2023 17:32
Exchange Announcement • 10 Mar 2023 17:32
Exchange Announcement • 10 Mar 2023 17:31
ENTITY
Myovant Sciences (MYOV US)
Myovant Sciences (MYOV US)
5
Analysis
Health Care • Japan
Myovant Sciences Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders. Myovant Sciences develops relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids and endometriosis-associated pain.
more
x